BTAX
BIOSTAX CORP
stock OTC

immune therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system. company's technology platform is built on two different immunotherapies, low dose naltrexone (ldn) and methionine-enkephalin (menk). both therapies have been decades in the making at institutions such as the pennsylvania state university medical school at hershey, university of chicago, state university of new york, and multiple sclerosis center at ucsf.